Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Erythropoietin use and the risk of stroke in patients on hemodialysis: A retrospective cohort study in Taiwan
 
  • Details

Erythropoietin use and the risk of stroke in patients on hemodialysis: A retrospective cohort study in Taiwan

Journal
Journal of the American Heart Association
Journal Volume
10
Journal Issue
14
Pages
e019529
Date Issued
2021
Author(s)
Hung P.-H.
Yeh C.-C.
Hsiao C.-Y.
Muo C.-H.
KUAN-YU HUNG  
Tsai K.-J.
DOI
10.1161/JAHA.120.019529
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111595009&doi=10.1161%2fJAHA.120.019529&partnerID=40&md5=7bf9d16dca4b2fb3b477ed5b487e1c97
https://scholars.lib.ntu.edu.tw/handle/123456789/578383
Abstract
BACKGROUND: Targeting higher hemoglobin levels with erythropoietin to treat anemia in patients with chronic kidney disease is associated with increased cardiovascular risk, including that of stroke. The risks of the subtypes of stroke, ischemic, hemorrhagic, and unspecified, following the administration of erythropoietin in patients with end-stage renal disease receiving hemodialysis remain unclear. METHODS AND RESULTS: Overall, 12 948 adult patients with end-stage renal disease treated during 1999 to 2010 who had undergone hemodialysis were included. The study end points were the incidences of stroke and its subtypes. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) of stroke and its subtypes in erythropoietin recipients compared with nonrecipients. Patients in the erythropoietin cohort did not have an increased risk of stroke compared with those in the nonerythropoietin cohort (adjusted HR, 1.03; 95% CI, 0.92–1.15). Compared with patients in the nonerythropoietin cohort, the risks of ischemic, hemorrhagic, or unspecified stroke were not higher in patients in the erythropoietin cohort (adjusted HRs, 1.08 [95% CI, 0.93–1.26], 0.96 [95% CI, 0.78–1.18], and 1.03 [95% CI, 0.80–1.32], respectively). Increased risks of stroke and its subtypes were not observed with even large annual defined daily doses of erythropoietin (>201). CONCLUSIONS: Erythropoietin in patients receiving hemodialysis is not associated with increased risk of stroke or any of its subtypes. ? 2021 The Authors.
Subjects
End-stage renal disease; Erythropoietin; Hemodialysis; Ischemic stroke
SDGs

[SDGs]SDG3

Other Subjects
erythropoietin; adolescent; adult; aged; cerebrovascular accident; chronic kidney failure; complication; dose response; female; hemodialysis; human; male; middle aged; proportional hazards model; retrospective study; Taiwan; very elderly; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Stroke; Taiwan; Young Adult
Publisher
American Heart Association Inc.
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science